Advertisement

Design and Construction of Poliovirus Epitope Expression Vectors

  • Karen L. Burke
  • Jeffrey W. Almond
  • David J. Evans
Part of the Methods in Molecular Biology book series (MIMB, volume 8)

Abstract

We have developed the very safe and efficacious live-attenuated Sabin 1 poliovirus vaccine strain as a vehicle for the presentation of defined epitopes from foreign pathogens (1, 2, 3). Precise modification of the poliovirus capsid is made possible by the application of recombinant DNA technology to cloned cDNA copies of the viral genome, which are infectious for mammalian cells in culture (4).

Keywords

Antigenic Site Chimeric Virus Unique Restriction Site Antigenic Domain Cassette Vector 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Burke, K. L., Evans, D.J., Jenkins, O., Meredith, J., D’Souza, E. D. S., and Almond, J. W. (1989) A cassette vector for the construction of antigen chimaeras of poliovirus. J. Gen. Virol. 70, 2475–2479.PubMedCrossRefGoogle Scholar
  2. 2.
    Evans, D. J., McKeating. J., Meredith, J, Burke, K. L., Katrak, K., John, A., Ferguson, M., Minor, P. D., Weiss, R. A., and Almond, J. W. (1989) An engineered poliovirus elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339, 385–388.PubMedCrossRefGoogle Scholar
  3. 3.
    Jenkins, O., Cason, J., Burke, K, L., Lunny, D., Gillen, A., Patel, D., McCance, D., and Almond, J. W. (1990) An antigen chimaera of poliovirus induces antibodies against Human Papillomavirus type 16. J. Virol. 64, 1201–1206.PubMedGoogle Scholar
  4. 4.
    Racaniello, V. R. and Baltimore, D. (1989) Cloned poliovirus complementary DNA is infectious in mammalian cell. Science 214, 916–919.CrossRefGoogle Scholar
  5. 5.
    Kitarnura, N., Semler, B. L., Rothberg, P. G., Larsen, G. R., Adler, C. J., Dorner, A. J., Emini, E. A., Hanecack, R., Lee, J. J., van der Werf, S., Anderson, C. W, and Wimmer, E. (1981) Primary structure, gene organization, polypeptide expression of poliovirus RNA. Nature 219, 547–553.CrossRefGoogle Scholar
  6. 6.
    Hogle, J. M., Chow, M., and Filman, D. J. (1985) The three-dimensional structure of poliovirus at 2.9A resolution. Science 229, 1358–1365.PubMedCrossRefGoogle Scholar
  7. 7.
    Filman, D. J., Syed, R., Chow, M., Macadam, A. J., Minor, P. D., and Hogle, J. M. (1989) Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8, 1567–1579.PubMedGoogle Scholar
  8. 8.
    Minor, P. D. (1989) Picornavirus antigenicity, in Current Topics in Immunology and Microbiology (in press).Google Scholar
  9. 9.
    Burke, K. L., Dunn, G., Ferguson, M., Minor, P. D., and Almond, J. W. (1988) Antigen chimaeras of poliovirus as potential new vaccines. Nature 332, 81,82.PubMedCrossRefGoogle Scholar
  10. 10.
    Murray, M. G., Kuhn, R. J., Arita, M., Kawamura, N., Nomoto, A., and Wimmer, E. (1988) Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc. Natl Acad. Sci. USA 85, 3202–3207.Google Scholar
  11. 11.
    Martin, A., Wychowksi, C, Couderc, C, Crainic, R, Hogle, J. M., and Girard, M. (1988) Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J. 7, 2839–2847.PubMedGoogle Scholar
  12. 12.
    Nomoto, A., Omata, T., Toyada, H., Kuge, S., Horie, H., Katoaka, Y., Genba, Y, Nakano, Y, and Imura, N. (1982) Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc. Natl Acad. Sci. USA 79, 5793–5797.PubMedCrossRefGoogle Scholar
  13. 13.
    Stanway, G., Hughes, P., Westrop, G. D., Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G.C., and Almond, J. W. (1986) Construction of poliovirus intertypic recombinants by use of cDNA. J. Vtrol. 57, 1187–1190.Google Scholar
  14. 14.
    Devereux, J, Haeberh, P., and Smithies, O. (1984) A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12, 387–395.PubMedCrossRefGoogle Scholar
  15. 15.
    Kramer, W., Drutsa, V., Jansen, H., Kramer, B., Pflugfelder, M., and Fritz, H. (1984) The gapped duplex DNA approach to oligonucleotide-directed mutation construction. Nucleic Acids Res. 12, 9441–9456.PubMedCrossRefGoogle Scholar
  16. 16.
    van der Werf, S., Bradley, J., Wimmer, E., Studier, F. W., and Dunn, J. J. (1986) Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc. Natl. Acad Sci. USA 83, 2330–2334.PubMedCrossRefGoogle Scholar
  17. 17.
    Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular cloning A Laboratory Manual Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.Google Scholar
  18. 18.
    Sarnow, P. (1989) Role of 3′-end sequences in infectivity of poliovirus transcripts made in vitro. J. Virol. 63, 467–470.PubMedGoogle Scholar
  19. 19.
    Saiki, R. K., Gelfand, D. H., Stoffel, S, Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., and Erhch, H. A. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487–491.PubMedCrossRefGoogle Scholar
  20. 20.
    Horton, R. M., Hunt, H. D, Ho, S. N., Pullen, J K, and Pease, L. R. (1989) Engineering hybrid genes without the use of restriction enzymes: Gene splicing by overlap extension. Gene 77, 61–68.PubMedCrossRefGoogle Scholar

Copyright information

© The Humana Press Inc., Clifton, NJ 1991

Authors and Affiliations

  • Karen L. Burke
    • 1
  • Jeffrey W. Almond
    • 2
  • David J. Evans
    • 2
  1. 1.Institut für Mikrobiologie der Universitat UlmAbteilung VirologieUlmFederal Republic of Germany
  2. 2.Department of MicrobiologyUniversity of ReadingReadingUK

Personalised recommendations